U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: March 24 - 30, 2024
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: March 24 - 30, 2024

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 03/29/2024
Location: Virtual
Subject: Foundation for the National Institutes of Health (FNIH) Roundtable on Imperatives for U.S. Clinical Research Leadership and Coordination
FDA Participant/Group: KEVIN BUGIN; ALI ABBASI; LESLEY CURTIS;
Non FDA Participant/Group: Government, industry, academia, and other invited participants

Official Name: Namandjé N. Bumpus, Ph.D., Principal Deputy Commissioner

No Significant Event

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 03/25/2024
Location: College Park, MD
Subject: Color Additives
FDA Participant/Group: JULIE BARROWS; JESSICA ROWDEN; STEVEN MUSSER; PRASHIELA MANGA; LINDA KATZ; STEVE HERMANSKY;
Non FDA Participant/Group: Several staff and board members from the International Association of Color Manufacturers

Event Date: 03/26/2024
Location: Atlanta, GA
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: DONALD PRATER; ANN OXENHAM; LARRY MORRIS;
Non FDA Participant/Group: Natalie Adan, Tyler Harper (Georgia Department of Agriculture);

Event Date: 03/27/2024
Location: Atlanta, GA
Subject: University of Georgia Center for Food Safety Annual Meeting; Keynote: FDA Foods Program Update
FDA Participant/Group: LARRY MORRIS; ANN OXENHAM; ORVILLE HARRIS;
Non FDA Participant/Group: Industry, government, academia, and University of Georgia staff and students

Event Date: 03/29/2024
Location: Virtual
Subject: Microplastics and Nanoplastics
FDA Participant/Group: NICHOLAS ALEXANDER; STACEY WIGGINS; RAYMOND BRINAS;
Non FDA Participant/Group: Alexandra C. Benton, Barrett Dudley, Tim Griffin (Arkansas, Office of the Attorney General);

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 03/25/2024
Location: Virtual
Subject: Public Health Outcomes
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: John Finley (AIS Healthcare); Halee Ackerman, Rai Downs (Tarplin, Downs & Young, LLC);

Event Date: 03/25/2024
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Heidi Ross (National Organization for Rare Disorders (NORD));

Event Date: 03/26/2024
Location: Virtual
Subject: Development of Neglected Tropical Disease Treatments and Technologies
FDA Participant/Group: N/A
Non FDA Participant/Group: Jacqueline Lagoy (Research!America);

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 03/28/2024
Location: Virtual
Subject: Supply Chain Resilience and Opportunities to Increase Collaboration in Third Countries for Good Manufacturing Practices Oversight
FDA Participant/Group: KATHERINE SERRANO; JOHN WEINER; SARAH MCMULLEN;
Non FDA Participant/Group: James Pound, Rachel Arunndale, Rebecca Gray (Medicines and Healthcare Products Regulatory Agency (MHRA));

Official Name: Michael Rogers, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Leah Hunter, Associate Commissioner for External Affairs

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 03/27/2024
Location: Boston, MA
Subject: 7th Annual Gene Therapy for Rare Disorders Summit 2024; Speaker: Establishing a Robust Framework to Facilitate the Development of Gene Therapy Products
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the 7th Annual Gene Therapy for Rare Disorders Summit 2024

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

Event Date: 03/24/2024
Location: Atlanta, GA
Subject: Association of Food and Drug Officials (AFDO) Healthy People 2030 Workgroup; Speaker: FDA Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, and other stakeholders

Event Date: 03/27/2024
Location: Virtual
Subject: Highly Pathogenic Avian Influenza (HPAI)
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives of the States' Governors Offices for OK, NM, TX, KS, and MN

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

Event Date: 03/27/2024
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: TIMOTHY SCHELL;
Non FDA Participant/Group: Catherine Alinovi (Healthy Pawsibilities); Roxanne Stone (Trinity Pet Food); Zach Ao (Viva Raw); Karen Neola (My Perfect Pet); Gary Tashjian (Darwins Pet Food);

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top